Overview
Dr. Michael J. Blaha MD MPH is Professor of Cardiology and Epidemiology and presently serves as the Director of Clinical Research for the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Director of the Cardiometabolic Clinic, and Program Director for the Preventive Cardiology Fellowship. His clinical interests include primary and secondary prevention of cardiovascular disease, with emphasis on early intervention in patients with advanced subclinical atherosclerosis detected with cardiac computed tomography. Dr. Blaha represents the 4th generation of physicians in his family. After earning a BS in pre-medical studies and classical civilization at the University of Notre Dame in 2001, Dr. Blaha went to Vanderbilt University where in 2006 he received his MD as well as an MPH. in clinical epidemiology and biostatistics. Dr. Blaha then completed his Internal Medicine residency in the Osler Medical Housestaff Training Program at Johns Hopkins in 2009 before completing a fellowship in Cardiology at Johns Hopkins in 2012. In 2018, Dr. Blaha received the Dr. Fred Brancati award at Johns Hopkins for excellence in mentoring. He has mentored over 30 trainees, many of which have gone on to hold prominent academic appointments. In 2021, Dr. Blaha was named to the Clarivate Highly Cited Researcher List, representing the top 1% of world’s researchers, and was first named to the Baltimore Magazine Best Doctors List. In 2022, he received the Arthur S. Agatston Cardiovascular Disease Prevention Award. Clinically, he practices as a preventive cardiologist specializing in cardiometabolic disease and in the interpretation of cardiac CT. His clinic specializes in patients with cardiometabolic disease and advanced subclinical atherosclerosis, and the focused use of an array of lifestyle and pharmacotherapies to mitigate that risk.
Dr. Blaha is rated as an Elite provider by MediFind in the treatment of High Cholesterol. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, High Cholesterol, Metabolic Syndrome, and Percutaneous Coronary Intervention (PCI).
His clinical research consists of co-authoring 898 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 57 articles in the study of High Cholesterol.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
10755 Falls Road, Pavilion I STE 360, Pavilion I STE 360, Lutherville, MD 21093
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
Roger Blumenthal is the Kenneth Jay Pollin Professor of Cardiology, professor of medicine and director of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease in Baltimore, Maryland. His principal clinical and research interests involve: 1) strategies to improve cardiovascular risk assessment to identify those adults at elevated risk and those at very low risk of cardiovascular disease and 2) the optimal management of atherosclerotic vascular disease. He is an expert in the pathogenesis, treatment and prevention of atherosclerotic vascular disease. Dr. Blumenthal was the principal developer of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. He is on the official national spokesperson panel for the American Heart Association and has co-written more than 600 articles dealing with many aspects of coronary heart disease and atherosclerosis management. An experienced writer, Dr. Blumenthal is on the editorial board of Circulation, Cardiology Today, and The American College of Cardiology and Extended Learning Center. He is a fellow of the American College of Cardiology and the American Heart Association’s Epidemiology and Prevention Council. He was co-editor-in-chief of the textbook Preventive Cardiology – A Companion to Braunwald’s Heart Disease. He received his medical degree from Cornell Medical College, where he was awarded the Weiss Prize for Excellence in Clinical Medicine. He did his internal medicine and cardiology fellowship training at The Johns Hopkins Hospital before joining the Johns Hopkins cardiology faculty. Dr. Blumenthal was the 2019 recipient of the Landon School Anthony Kupka Distinguished Alumnus Award. He was co-chairperson of the 2019 American College of Cardiology/American Heart Guideline on prevention of cardiovascular disease. Dr. Blumenthal is rated as an Elite provider by MediFind in the treatment of High Cholesterol. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Metabolic Syndrome, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.
The Heart Group Of Lancaster General Health
Rolf Andersen is a Cardiologist in Lancaster,, Pennsylvania. Dr. Andersen is rated as a Distinguished provider by MediFind in the treatment of High Cholesterol. His top areas of expertise are High Cholesterol, Defective Apolipoprotein B-100, Homozygous Familial Hypercholesterolemia (HoFH), and Coronary Heart Disease.
Cardiology Consultants P A
David Ramos is a Cardiologist in Dover,, Delaware. Dr. Ramos is rated as a Distinguished provider by MediFind in the treatment of High Cholesterol. His top areas of expertise are Dilated Cardiomyopathy (DCM), Cardiomyopathy, High Cholesterol, and Angina.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- AtherosclerosisDr. Blaha isElite. Learn about Atherosclerosis.
- Coronary Heart DiseaseDr. Blaha isElite. Learn about Coronary Heart Disease.
- High CholesterolDr. Blaha isElite. Learn about High Cholesterol.
- Distinguished
- Atrial FibrillationDr. Blaha isDistinguished. Learn about Atrial Fibrillation.
- Heart AttackDr. Blaha isDistinguished. Learn about Heart Attack.
- HypertensionDr. Blaha isDistinguished. Learn about Hypertension.
- Metabolic SyndromeDr. Blaha isDistinguished. Learn about Metabolic Syndrome.
- Advanced
- Abdominal Obesity Metabolic Syndrome
- Aortic RegurgitationDr. Blaha isAdvanced. Learn about Aortic Regurgitation.
- Aortic Valve StenosisDr. Blaha isAdvanced. Learn about Aortic Valve Stenosis.
- ApoplexyDr. Blaha isAdvanced. Learn about Apoplexy.
- ArrhythmiasDr. Blaha isAdvanced. Learn about Arrhythmias.
- Arterial EmbolismDr. Blaha isAdvanced. Learn about Arterial Embolism.
- Experienced
- Acute Coronary SyndromeDr. Blaha isExperienced. Learn about Acute Coronary Syndrome.
- AnginaDr. Blaha isExperienced. Learn about Angina.
- Bidirectional TachycardiaDr. Blaha isExperienced. Learn about Bidirectional Tachycardia.
- Cardiac ArrestDr. Blaha isExperienced. Learn about Cardiac Arrest.
- CardiomyopathyDr. Blaha isExperienced. Learn about Cardiomyopathy.
- Catecholaminergic Polymorphic Ventricular Tachycardia